Last reviewed · How we verify

NCT05908214: MnHyperex

The Application of Wide Pulse High Frequency Neuromuscular Electrical Stimulation in Disorders Associated With Motoneuron Hyperexcitability

Recruiting now NA Last updated 28 November 2023
What this trial tests

NA trial testing wide pulse high frequency neuromuscular electrical stimulation training in Stroke in 110 participants. Currently enrolling.

Timeline
1 October 2023
Primary endpoint
31 December 2025
31 December 2026

Quick facts

Lead sponsorUniversity of Lausanne
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment110
Start date1 October 2023
Primary completion31 December 2025
Estimated completion31 December 2026
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Lausanne

Who can join

18 and older, any sex, with Stroke or Cramp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the present project, the investigators aim at proposing innovative ways of investigating spinal motoneuron hyperexcitability to counteract the associated impairments by using wide pulse high frequency neuromuscular electrical stimulation (WPHF NMES) in various populations. The investigators will use WPHF NMES contractions as a model to gain insights into the mechanisms underlying muscle cramps, restless legs syndrome or stroke-induced spasticity as there is evidence that they share common underlying mechanisms. The investigators will then use WPHF NMES as a training modality to improve plantar flexor neuromuscular function in stroke patients by taking advantage of their motoneuronal hyperexcitability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Lausanne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05908214.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing